• P-ISSN 0974-6846 E-ISSN 0974-5645

Indian Journal of Science and Technology


Indian Journal of Science and Technology

Year: 2023, Volume: 16, Issue: 43, Pages: 3911-3916

Original Article

Relationship Between Glycosylated Haemoglobin and Dyslipidaemia in Individuals Exposed to COVID-19: A Cross Sectional Study in North Indian Population

Received Date:29 January 2023, Accepted Date:08 October 2023, Published Date:17 November 2023


Objective: To investigate the correlation between Glycosylated Hemoglobin and dyslipidemia in individuals exposed to COVID-19 in the Delhi/NCR region. Method: In the Delhi/NCR region, a total of 521 patient fasting blood samples were gathered from a NABL Accredited labs. These samples, collected between July 2020 and March 2022, consisted of 334 males and 187 females. HbA1C and lipid profile tests for the patients were conducted using conventional methods at a laboratory located in Gurugram. Findings: Among diabetic patients below 40 years of age, the mean HDL levels decreased to 40.3% compared to 42 mg/dl in non-diabetics. Increased glycosylated hemoglobin [more than 7%] with dyslipidemia noted in males 114 compared to females 64. A significant decrease in HDL levels were observed in diabetic patients above 40 years of age, with the mean level of HDL dropping to 33 mg/dl. The dyslipidemia was present in 80.9% of male diabetic patients and 88.6% of female diabetic patients. In diabetic male patients, a correlation between increasing triglyceride levels and the decreased HDL levels found. The mean triglyceride level in diabetic patients was 199 mg/dl, while the mean HDL level was 42 mg/dl. On the other hand, non-diabetic individuals had a mean triglyceride level of 105 mg/dl and an HDL level of 44 mg/dl. Novelty: Dyslipidemia is significantly associated with poorly controlled HbAa1c in T2DM than non-diabetic subjects after covid exposure. This observation points towards a U-shaped correlation between HDL and glycated haemoglobin in diabetic patients.

Keywords: Glycosylated haemoglobin, Dyslipidemia, Cardivascular disease, High density lipoprotein Diabetes mellitus (DM), coronary heart disease (CHD)


  1. Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. European Journal of Clinical Nutrition. 2017;71(7):816–824. Available from: https://doi.org/10.1038/ejcn.2017.40
  2. Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India. Current epidemiology and future directions. Circulation. 2016;133(16):1605–1620. Available from: https://doi.org/10.1161/CIRCULATIONAHA.114.008729
  3. Priya JK, Balambigai MS, Sariga N, Sathya M, Andhuvan G. Development and validation of patient information leaflet for heart attack patients. International Journal of Pharmacy and Pharmaceutical Sciences. 2016;8(8):381–383. Available from: https://www.researchgate.net/publication/306225470_Development_and_validation_of_patient_information_leaflet_for_heart_attack_patients
  4. Ali MK, Narayan KMV, Tandon N. Diabetes and coronary heart disease: Current perspectives. Indian Journal of Medical Research. 2010;132(5):584–597. Available from: https://pubmed.ncbi.nlm.nih.gov/21150011/
  5. Mokta J, Mokta K, Ranjan A, Garg M. Prevalence of Cardiovascular Risk Factors among Diabetic Population and Awareness of Diabetes among Diabetic Patients: A Population Based Himalayan Study. Journal of the Association of Physicians of India. 2017;65(2):48–52. Available from: https://pubmed.ncbi.nlm.nih.gov/28457032/
  6. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine. 1998;339(4):229–234. Available from: https://doi.org/10.1056/NEJM199807233390404
  7. Hu Z, Youn HM, Quan J, Lee LLS, Mak IL, Yu EYT, et al. The indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: Systematic review and meta-analysis. Primary Care Diabetes. 2023;17(3):229–237. Available from: https://doi.org/10.1016/j.pcd.2023.02.006
  8. Mateo-Gallego R, Gracia-Rubio I, Garza MC, Cebollada A, Pérez-Calahorra S, Bayona-Sánchez A, et al. The impact of the COVID-19 pandemic in diabetes and dyslipidemia management in a Spanish region: a retrospective study of the Aragon population. Frontiers in Medicine. 2023;10:1–9. Available from: https://doi.org/10.3389/fmed.2023.1191026
  9. Sankar P, Ahmed WN, Koshy VM, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(6):1815–1819. Available from: https://doi.org/10.1016/j.dsx.2020.09.005
  10. SKA, EYA, Alguwaihes AM, Alfadda A, Al-Sofiani ME. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia. Diabetes Research and Clinical Practice. 2021;173:1–8. Available from: https://doi.org/10.1016/j.diabres.2021.108682
  11. Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clinical Diabetes and Endocrinology. 2015;1(1):1–7. Available from: https://doi.org/10.1186/s40842-015-0004-6
  12. Kidwai SS, Nageen A, Bashir F, Ara J. HbA1c – A predictor of dyslipidemia in type 2 Diabetes Mellitus. Pakistan Journal of Medical Sciences. 2020;36(6):1339–1343. Available from: https://doi.org/10.12669/pjms.36.6.2000
  13. Alzahrani SH, Baig M, Aashi MM, Al-shaibi FK, Alqarni DA, Bakhamees WH. Association between glycated hemoglobin [HbA1c] and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2019;12:1639–1644. Available from: https://doi.org/10.2147/DMSO.S222271
  14. Wrona M, Skrypnik D. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection—Systematic Review. International Journal of Environmental Research and Public Health. 2022;19(20):1–10. Available from: https://doi.org/10.3390/ijerph192013280
  15. Rosso LG, Lhomme M, Meroño T, Dellepiane A, Sorroche P, Hedjazi L, et al. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2017;1862(2):188–195. Available from: https://doi.org/10.1016/j.bbalip.2016.10.014
  16. Parikh RM, SRJ, Menon PS, Shah NS. Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2010;4(1):10–12. Available from: https://doi.org/10.1016/j.dsx.2009.04.005


© 2023 Kumar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Indian Society for Education and Environment (iSee)


Subscribe now for latest articles and news.